Cooper Companies (COO) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Cooper Companies (COO) over the last 10 years. The current PE ratio for Cooper Companies as of August 18, 2017 is 27.21.
|Medical||Medical & Dental Supplies||$11.979B||$1.967B|
|The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical lenses and lenses for patients with more complex vision disorders. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women's healthcare market.|